Subtype
Digestive System Adenocarcinoma
CI-CAN-00002525Explore in graph →
1,374 active trials24 approved drugs77 evidence items
- NCIt
- C210140
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00002525Explore in graph →
Clinical trials
5,072 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (619)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00792350 | INSIGHT - Post Marketing Surveillance(INSIGHT) | completed | — | 791 | BayerINDUSTRY | 2 | May 14, 2014 | clinicaltrials |
| NCT01082809 | Sunitinib as Second-line Treatment in Advanced Biliary Tract Carcinoma | completed | Phase 2 | 59 | Samsung Medical CenterOTHER | 1 | May 14, 2014 | clinicaltrials |
| Genome-wide Association Study to Predict Treatment Response for Molecular Targeted Therapy in Hepatocellular Carcinoma and Renal Cell Carcinoma |
| completed |
| — |
| 200 |
| Samsung Medical CenterOTHER |
| 1 |
| May 14, 2014 |
| clinicaltrials |
| NCT02131441 | Surgical Specification and Efficacy Evaluation of Total Laparoscopic Left Liver Resection | unknown | N/A | 2 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | May 6, 2014 | clinicaltrials |
| NCT01124786 | A Study Comparing CO-1.01 With Gemcitabine as First Line Therapy in Patients With Metastatic Pancreatic Adenocarcinoma (LEAP) | completed | Phase 2 | 367 | Clovis Oncology, Inc.INDUSTRY | 15 | Apr 17, 2014 | clinicaltrials |
| NCT00044512 | A Study to Estimate Safety and Efficacy of Sorafenib (BAY43-9006) in the Treatment of Hepatocellular Carcinoma | completed | Phase 2 | 137 | BayerINDUSTRY | 5 | Apr 16, 2014 | clinicaltrials |
| NCT00203892 | Study of CAP1-6D in Patients With Locally Advanced or Surgically Resected Pancreatic Adenocarcinoma | completed | Phase 1 / Phase 2 | 23 | University of ChicagoOTHER | 1 | Apr 16, 2014 | clinicaltrials |
| NCT00492752 | A Randomized, Double-Blinded, Placebo-Controlled Study of Sorafenib in Patients With Advanced Hepatocellular Carcinoma | completed | Phase 3 | 226 | BayerINDUSTRY | 3 | Apr 16, 2014 | clinicaltrials |
| NCT01435525 | Nexium Capsules Helicobacter Pylori Specific Clinical Experience Investigation | completed | — | 369 | AstraZenecaINDUSTRY | 1 | Apr 16, 2014 | clinicaltrials |
| NCT01957241 | PLA for HCC and Esophageal ca Serum | unknown | — | 164 | National Taiwan University HospitalOTHER | 1 | Apr 16, 2014 | clinicaltrials |
| NCT01233505 | Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors | terminated | Phase 1 | 16 | National Cancer Institute (NCI)NIH | 1 | Apr 2, 2014 | clinicaltrials |
| NCT02090062 | Difference in H. Pylori Infection Rate of EGC Patients Before and After Endoscopic Resection | unknown | — | 60 | Shanghai Jiao Tong University School of MedicineOTHER | 0 | Mar 19, 2014 | clinicaltrials |
| NCT00142428 | Cetuximab in Patients With Unresectable or Metastatic Hepatocellular Carcinoma | completed | Phase 2 | 30 | Massachusetts General HospitalOTHER | 1 | Mar 18, 2014 | clinicaltrials |
| NCT00142467 | Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Patients With Hepatocellular Carcinoma | completed | Phase 2 | 33 | Massachusetts General HospitalOTHER | 1 | Mar 18, 2014 | clinicaltrials |
| NCT00361309 | SU011248 in Advanced Hepatocellular Carcinoma | completed | Phase 2 | 34 | Massachusetts General HospitalOTHER | 1 | Mar 18, 2014 | clinicaltrials |
| NCT01116635 | Clinical Study Examining the Safety and Efficacy of Doxorubicin Drug Eluting Microspheres Transarterial Embolization in the Setting of Hepatocellular Carcinoma (HCC) | completed | Phase 1 / Phase 2 | 24 | University of British ColumbiaOTHER | 1 | Mar 17, 2014 | clinicaltrials |
| NCT01215565 | Study of Sunitinib in Patients With Advanced/Inoperable Fibrolamellar Carcinoma(Fibrolam) | terminated | Phase 2 | 4 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Mar 13, 2014 | clinicaltrials |
| NCT02082691 | Continued Administration of G-202 for One Patient With Advanced Hepatocellular Carcinoma | no longer available | — | — | Devalingam MahalingamOTHER | 0 | Mar 10, 2014 | clinicaltrials |
| NCT02074202 | To Evaluate the Efficacy and Safety of (18F-FCH) Comparing With (18F-FDG) for Detecting Hepatocellular Carcinoma | unknown | Phase 3 | 150 | National Taiwan University HospitalOTHER | 1 | Feb 28, 2014 | clinicaltrials |
| NCT00763776 | Parenchyma Resection of Cirrhotic Liver by the Clamp Crushing Technique and the Ultrasonic Dissector(SECCI) | terminated | N/A | 27 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Feb 27, 2014 | clinicaltrials |
| NCT02070822 | 3T MRI to Predict TACE Response of HCC | unknown | — | 100 | National Taiwan University HospitalOTHER | 1 | Feb 25, 2014 | clinicaltrials |
| NCT00462553 | Sunitinib and Gemcitabine in Treating Patients With Pancreatic Cancer or Other Solid Tumors | completed | Phase 1 | 37 | National Cancer Institute (NCI)NIH | 1 | Feb 24, 2014 | clinicaltrials |
| NCT01145456 | Gamma-Secretase Inhibitor RO4929097 and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 18 | National Cancer Institute (NCI)NIH | 1 | Feb 24, 2014 | clinicaltrials |
| NCT02061956 | A Simple Prognostic Scoring System for Patients Receiving Transarterial Chemoembolization for Hepatocellular Carcinoma | completed | — | 647 | Sun Yat-sen UniversityOTHER | 1 | Feb 13, 2014 | clinicaltrials |
| NCT02051283 | Pretreatment MRI Predicting Outcome After Radio-frequency Ablation of HCC | unknown | — | 200 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Jan 31, 2014 | clinicaltrials |
| NCT01096914 | Radiofrequency Versus Laser Ablation for Hepatocellular Carcinoma | completed | N/A | 140 | Cardarelli HospitalOTHER | 1 | Jan 30, 2014 | clinicaltrials |
| NCT01806753 | Performance of Endoscopic Submucosal Dissection According to the Sedation Method | completed | N/A | 157 | Yonsei UniversityOTHER | 1 | Jan 30, 2014 | clinicaltrials |
| NCT01501240 | Gadoxetic Acid-enhanced MR Evaluation of Hepatocellular Carcinoma and Dysplastic Nodules in the Cirrhotic Liver(PriMPa) | withdrawn | — | 0 | Jae Ho ByunOTHER | 1 | Jan 28, 2014 | clinicaltrials |
| NCT01403103 | Cholecalciferol(25-[OH]-Vitamin D) in Treating Patients With Colorectal Cancer | withdrawn | Early Phase 1 | 0 | Case Comprehensive Cancer CenterOTHER | 0 | Jan 17, 2014 | clinicaltrials |
| NCT00943449 | 4SC-201 (Resminostat) and Sorafenib in Advanced Hepatocellular Carcinoma(Shelter) | completed | Phase 2 | 57 | 4SC AGINDUSTRY | 2 | Jan 16, 2014 | clinicaltrials |
| NCT02036216 | Circulating Cell-free DNA as a Predictive Biomarker for Hepatocelluar Carcinoma. | unknown | — | 200 | Peking Union Medical College HospitalOTHER | 2 | Jan 14, 2014 | clinicaltrials |
| NCT02032368 | Decrease in Circulating Tumour Cell Count Reflects the Effectiveness of Postoperative Adjuvant Transarterial Chemoembolization (TACE) in Preventing Hepatocellular Carcinoma Recurrence | completed | N/A | 57 | Guangdong Provincial People's HospitalOTHER | 1 | Jan 10, 2014 | clinicaltrials |
| NCT02031952 | Hepatectomy Versus Hepatectomy With Lymphadenectomy in Hepatocellular Carcinoma | completed | N/A | 87 | Sun Yat-sen UniversityOTHER | 1 | Jan 9, 2014 | clinicaltrials |
| NCT01096732 | Hedgehog Inhibition for Pancreatic Ductal Adenocarcinoma (PDAC) in the Preoperative Setting (HIPPoS)(HIPPoS) | terminated | Phase 2 | 3 | Lisa BaxOTHER | 1 | Jan 8, 2014 | clinicaltrials |
| NCT02025842 | Hepatitis B Virus HBeAg-negative Genotype D Patients and Hepatocellular Carcinoma(HBV/HCC) | completed | — | 306 | Azienda Ospedaliera San Camillo ForlaniniOTHER | 0 | Jan 1, 2014 | clinicaltrials |
| NCT01828762 | Autologous Immune Cell Therapy in Primary Hepatocellular Carcinoma Patients Following Resection and TACE Therapy(DC-TC) | completed | N/A | 8 | Shanghai AbelZeta Ltd.INDUSTRY | 1 | Dec 23, 2013 | clinicaltrials |
| NCT00494299 | Phase III Study of BAY43-9006 in Patients With Advanced Hepatocellular Carcinoma (HCC) Treated After Transcatheter Arterial Chemoembolization (TACE) | completed | Phase 3 | 458 | BayerINDUSTRY | 2 | Dec 20, 2013 | clinicaltrials |
| NCT00719550 | AMG 102 Plus ECX for Unresectable Locally Advanced or Metastatic Gastric or Esophagogastric Junction Cancer | completed | Phase 1 / Phase 2 | 130 | AmgenINDUSTRY | 0 | Dec 5, 2013 | clinicaltrials |
| NCT00357474 | Comparison Study of Transarterial Chemoembolization and Percutaneous Ethanol Injection for Multiple, Small HCCs | completed | Phase 3 | 22 | Seoul National University HospitalOTHER | 1 | Dec 4, 2013 | clinicaltrials |
| NCT00464893 | Phase II Study With Catumaxomab in Patients With Gastric Cancer After Neoadjuvant CTx and Curative Resection | completed | Phase 2 | 70 | Neovii BiotechINDUSTRY | 4 | Dec 4, 2013 | clinicaltrials |
| NCT01997957 | A RCT of Oral S-1 in Combination With Sequential HAIC of Oxaliplatin After TACE in Patients With Advanced HCC(SOON) | unknown | Phase 4 | 110 | Zhu XuOTHER | 1 | Nov 28, 2013 | clinicaltrials |
| NCT01129570 | Siliphos in Advanced Hepatocellular Carcinoma | completed | Phase 1 | 3 | Abby SiegelOTHER | 1 | Nov 25, 2013 | clinicaltrials |
| NCT01930383 | Circulating Tumor Cells for Hepatocellular Carcinoma(CTCs for HCC) | unknown | — | 150 | National Taiwan University HospitalOTHER | 1 | Nov 14, 2013 | clinicaltrials |
| NCT01128803 | Immunotherapy of Hepatocellular Carcinoma by Induction of Anti-alpha Fetoprotein Response | terminated | Phase 1 / Phase 2 | 1 | Nantes University HospitalOTHER | 1 | Nov 7, 2013 | clinicaltrials |
| NCT01098760 | Hepatocellular Carcinoma - Advanced Stage - Sorafenib Trial in Taiwanese Patients(HATT) | completed | Phase 4 | 151 | BayerINDUSTRY | 1 | Oct 31, 2013 | clinicaltrials |
| NCT01320852 | PET Scan as a Screening Tool for Liver Transplant in Patients With Hepatocellular Carcinoma (HCC) | completed | N/A | 100 | McGill University Health Centre/Research Institute of the McGill University Health CentreOTHER | 1 | Oct 25, 2013 | clinicaltrials |
| NCT01215838 | MRI of the Liver With Eovist | terminated | — | 4 | University of WashingtonOTHER | 0 | Oct 14, 2013 | clinicaltrials |
| NCT01962519 | Early Oral Feeding After Total Gastrectomy for Cancer | unknown | N/A | 112 | Jagiellonian UniversityOTHER | 1 | Oct 14, 2013 | clinicaltrials |
| NCT00003835 | Combination Chemotherapy in Treating Patients With Stage III Colon Cancer | completed | Phase 3 | 1,260 | National Cancer Institute (NCI)NIH | 1 | Oct 8, 2013 | clinicaltrials |
| NCT00077545 | 3-AP Plus Cisplatin in Treating Patients With Recurrent or Metastatic Adenocarcinoma of the Esophagus or Gastroesophageal Junction | completed | Phase 2 | 39 | National Cancer Institute (NCI)NIH | 1 | Oct 8, 2013 | clinicaltrials |
Data updated 24 days agoSource updated May 14, 2014source: clinicaltrials